The clinical potential of ex vivo lung perfusion

References

• Ware LB, Wang Y, Fang X et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet360(9333), 619–620 (2002).
   PubMedGoogle Scholar
• Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation75(12), 1928–1933 (2003).
   PubMed Web of Science ®Google Scholar
• de Perrot M, Liu M, Waddell T, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am. J. Respir. Cell Mol. Biol.28(5), 616–625 (2003).
   PubMedGoogle Scholar
• Aigner C, Winkler G, Jaksch P et al. Extended donor criteria for lung transplantation – a clinical reality. Eur. J. Cardiothorac. Surg.27(5), 757–761 (2005).
   PubMed Web of Science ®Google Scholar
• Van Raemdonck D, Neyrinck A, Verleden GM et al. Lung donor selection and management. Proc. Am. Thorac. Soc.6(1), 28–38 (2009).
   PubMedGoogle Scholar
• Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin. Chest Med.32(2), 233–244 (2011).
   PubMed Web of Science ®Google Scholar
• De Oliveira NC, Osaki S, Maloney JD et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J. Thorac. Cardiovasc. Surg.139(5), 1306–1315 (2010).
   PubMedGoogle Scholar
• Cypel M, Sato M, Yildirim E et al. Initial experience with lung donation after cardiocirculatory death in Canada. J. Heart Lung Transplant.28(8), 753–758 (2009).
   PubMedGoogle Scholar
• Snell GI, Levvey BJ, Oto T et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am. J. Transplant.8(6), 1282–1289 (2008).
   PubMedGoogle Scholar
• Mason DP, Thuita L, Alster JM et al. Should lung transplantation be performed using donation after cardiac death? The United States experience. J. Thorac. Cardiovasc. Surg.136(4), 1061–1066 (2008).
   PubMed Web of Science ®Google Scholar
• Aigner C, Mazhar S, Jaksch P et al. Lobar transplantation, split lung transplantation and peripheral segmental resection – reliable procedures for downsizing donor lungs. Eur. J. Cardiothorac. Surg.25(2), 179–183 (2004).
   PubMed Web of Science ®Google Scholar
• Yamane M, Date H, Okazaki M, Toyooka S, Aoe M, Sano Y. Long-term improvement in pulmonary function after living donor lobar lung transplantation. J. Heart Lung Transplant.26(7), 687–692 (2007).
   PubMedGoogle Scholar
• Carrel A, Lindbergh CA. The culture of whole organs. Science81(2112), 621–623 (1935).
   PubMedGoogle Scholar
• Jirsch DW, Fisk RL, Couves CM. Ex vivo evaluation of stored lungs. Ann. Thorac. Surg.10(2), 163–168 (1970).
   PubMedGoogle Scholar
• Fisk RL, Symes JF, Aldridge LL, Couves CM. The pathophysiology and experimental therapy of acid pneumonitis in ex vivo lungs. Chest57(4), 364–370 (1970).
   PubMedGoogle Scholar
• Cushman DW, Wang FL, Fung WC et al. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br. J. Clin. Pharmacol.28(Suppl. 2), S115–S130; discussion S130–S131 (1989).
   PubMed Web of Science ®Google Scholar
• Kanekal S, Plopper C, Morin D, Buckpitt A. Metabolic activation and bronchiolar Clara cell necrosis from naphthalene in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther.252(1), 428–437 (1990).
   PubMedGoogle Scholar
• Kaplan E, Diehl JT, Peterson MB et al. Extended ex vivo preservation of the heart and lungs. Effects of acellular oxygen-carrying perfusates and indomethacin on the autoperfused working heart-lung preparation. J. Thorac. Cardiovasc. Surg.100(5), 687–697; discussion 697–688 (1990).
   PubMed Web of Science ®Google Scholar
• Seeger W, Schneider U, Kreusler B et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood76(7), 1438–1444 (1990).
   PubMed Web of Science ®Google Scholar
• Townsley MI, Barman SA, Taylor AE. Pulmonary embolism: emboli and fibrinolysis inhibition in isolated canine lungs. Am. J. Physiol.258(3 Pt 2), H754–H758 (1990).
   PubMedGoogle Scholar
• Wang LS, Yoshikawa K, Miyoshi S et al. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J. Thorac. Cardiovasc. Surg.98(3), 333–342 (1989).
   PubMed Web of Science ®Google Scholar
• Brasile L, Stubenitsky BM, Kootstra G. Solving the organ shortage: potential strategies and the likelihood of success. ASAIO J.48(3), 211–215 (2002).
   PubMedGoogle Scholar
• Brasile L, Stubenitsky BM, Booster MH et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation73(6), 897–901 (2002).
   PubMed Web of Science ®Google Scholar
• Brasile L, Buelow R, Stubenitsky BM, Kootstra G. Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation76(8), 1145–1149 (2003).
   PubMedGoogle Scholar
• Brasile L, Stubenitsky BM, Booster MH, Haisch C, Kootstra G. NOS: the underlying mechanism preserving vascular integrity and during ex vivo warm kidney perfusion. Am. J. Transplant.3(6), 647–649 (2003).
   Google Scholar
• Brasile L, Stubenitsky BM, Haisch CE, Kon M, Kootstra G. Repair of damaged organs in vitro. Am. J. Transplant.5(2), 300–306 (2005).
   PubMed Web of Science ®Google Scholar
• Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation73(5), 701–709 (2002).
   PubMed Web of Science ®Google Scholar
• Steen. S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjöberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann. Thorac. Surg.76(1), 244–252 (2003).
   PubMed Web of Science ®Google Scholar
• Daemen JW, Kootstra G, Wijnen RM, Yin M, Heineman E. Nonheart-beating donors: the Maastricht experience. Clin. Transpl.303–316 (1994).
   PubMedGoogle Scholar
• Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet357, 825–829 (2001).
   PubMed Web of Science ®Google Scholar
• Meers CM, Tsagkaropoulos S, Wauters S et al. A model of ex vivo perfusion of porcine donor lungs injured by gastric aspiration: a step towards pretransplant reconditioning. J. Surg. Res.170(1), e159–e167 (2011).
   PubMedGoogle Scholar
• Egan TM, Haitchcock JA, Nicotra WA, Koukoulis G, Inokawa H, Sevala M. Ex vivo evaluation of human lungs for transplant suitability. Ann. Thorac. Surg.81(4), 1205–1213 (2006).
   PubMedGoogle Scholar
• Snell GI, Oto T, Levvey B et al. Evaluation of techniques for lung transplantation following donation after cardiac death. Ann. Thorac. Surg.81(6), 2014–2019 (2006).
   PubMedGoogle Scholar
• Neyrinck AP, Van De Wauewer C, Geudens N, Rega FR, Verleden GM, Wouters Comparative study of donor lung injury in heart-beating versus non-heart-beating donors. Eur. J. Cardiothorac. Surg.30(4), 628–636 (2006).
   PubMedGoogle Scholar
• Rega FR, Vanaudenaerde BM, Wuyts WA et al. IL-1beta in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor. J. Heart Lung Transplant.24(1), 20–28 (2003).
   Google Scholar
• Cypel M, Yeung JC, Hirayama S et al. Technique for prolonged normothermic ex vivo lung perfusion. J. Heart Lung Transplant.27(12), 1319–1325 (2008).
   PubMed Web of Science ®Google Scholar
• Cypel M, Rubacha M, Yeung J et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am. J. Transplant.9(10), 2262–2269 (2009).
   PubMed Web of Science ®Google Scholar
• Cypel M, Liu M, Rubacha M et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci. Transl. Med.1(4), 1–9 (2009).
   Google Scholar
• Steen S, Sjoberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet357(9259), 825–829 (2001).
   PubMed Web of Science ®Google Scholar
• Ingemansson R, Eyjolfsson A, Mared L et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann. Thorac. Surg.87(1), 255–260 (2009).
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Hlebowicz J, Koul B et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. Interact. Cardiovasc. Thorac. Surg.12(2), 162–165 (2011).
   PubMedGoogle Scholar
• Cypel M, Yeung JC, Liu M et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N. Engl. J. Med.364(15), 1431–1440 (2011).
   PubMed Web of Science ®Google Scholar
• Christie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest127(1), 161–165 (2005).
   PubMedGoogle Scholar
• Yeung C, Koike T, Cypel M et al. Airway pressure and compliance in the evaluation of donor lung injury during protective ex vivo lung perfusion in a porcine brain death model. J. Heart Lung Transplant.30(4), S143 (2011).
   Google Scholar
• Orens JB, Boehler A, de Perrot M et al. A review of lung transplant donor acceptability criteria. J. Heart Lung Transplant.22(11), 1183–1200 (2003).
   PubMed Web of Science ®Google Scholar
• Kaneda H, Waddell TK, de Perrot M et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am. J. Transplant.6(3), 544–551 (2006).
   PubMedGoogle Scholar
• Cypel M, Yildirim E, Boasquevisque C et al. Donor scoring does not predict early outcome. J. Heart Lung Transplant.26(2 Suppl. 1), S212–S213 (2008).
   Google Scholar
• Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant.24(10), 1454–1459 (2005).
   PubMed Web of Science ®Google Scholar
• de Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J. Heart Lung Transplant.24(10), 1460–1467 (2005).
   PubMedGoogle Scholar
• De Perrot M, Sekine Y, Fischer S et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am. J. Respir. Crit. Care Med.165(2), 211–215 (2002).
   PubMedGoogle Scholar
• Fisher AJ, Donnelly SC, Hirani N et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am. J. Respir. Crit. Care Med.163(1), 259–265 (2001).
   PubMed Web of Science ®Google Scholar
• Anraku M, Cameron MJ, Waddell TK et al. Impact of Human Donor Lung Gene Expression Profiles on Survival after Lung Transplantation: a case–control study. Am. J. Transplant.8(10), 2140–2148 (2008).
   PubMedGoogle Scholar
• Kang CH, Anraku M, Cypel M et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J. Heart Lung Transplant.30(3), 289–298 (2011).
   PubMedGoogle Scholar
• Ray M, Dharmarajan S, Freudenberg J, Zhang W, Patterson GA. Expression profiling of human donor lungs to understand primary graft dysfunction after lung transplantation. Am. J. Transplant.7(10), 2396–2405 (2007).
   PubMedGoogle Scholar
• Das J, Kelley SO. Protein detection using arrayed microsensor chips: tuning sensor footprint to achieve ultrasensitive readout of CA-125 in serum and whole blood. Anal. Chem.83(4), 1167–1172 (2011).
   PubMedGoogle Scholar
• Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am. J. Physiol. Lung Cell Mol. Physiol.293(1), 52–59 (2007).
   PubMed Web of Science ®Google Scholar
• Sakuma T, Gu X, Wang Z et al. Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit. Care Med.34(3), 676–681 (2006).
   PubMed Web of Science ®Google Scholar
• Frank JA, Briot R, Lee JW, Ishizaka A, Uchida T, Matthay MA. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am. J. Physiol. Lung Cell Mol. Physiol.293(1), L52–59 (2007).
   PubMed Web of Science ®Google Scholar
• Planes C, Blot-Chabaud M, Matthay MA, Couette S, Uchida T, Clerici C. Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. J. Biol. Chem.277(49), 47318–47324 (2002).
   PubMed Web of Science ®Google Scholar
• Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI. The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation. J. Heart Lung Transplant.27(1), 78–85 (2008).
   PubMedGoogle Scholar
• Inci I, Zhai W, Arni S et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J. Heart Lung Transplant.26(10), 1054–1060 (2007).
   PubMed Web of Science ®Google Scholar
• Karamanou DM, Perry J, Walden HR et al. The effect of ex-vivo perfusion on the microbiological profile of the donor lung. J. Heart Lung Transplant.29(2 Suppl.), S88 (2010).
   Google Scholar
• Inci I, Ampollini L, Arni S et al.Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J. Heart Lung Transplant.27(11), 1229–1236 (2008).
   PubMed Web of Science ®Google Scholar
• Hirayama S, Cypel M, Sato M et al. Activated protein C in ischemia-reperfusion injury after experimental lung transplantation. J. Heart Lung Transplant.28(11), 1180–1184 (2009).
   PubMed Web of Science ®Google Scholar
• Nita I, Hollander C, Westin U, Janciauskiene SM. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir. Res.6, 12 (2005).
   PubMed Web of Science ®Google Scholar
• Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J. Thorac. Cardiovasc. Surg.130(1), 194–201 (2005).
   PubMed Web of Science ®Google Scholar
• Fischer S, Liu M, MacLean AA et al.In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia–reperfusion injury and improves early posttransplant graft function in the rat. Hum. Gene Ther.12(12), 1513–1526 (2001).
   PubMed Web of Science ®Google Scholar
• Martins S, de Perrot M, Imai Y et al. Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther.11(24), 1786–1796 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao M, Fernandez LG, Doctor A et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia–reperfusion injury. Am. J. Physiol. Lung Cell Mol. Physiol.291(5), L1018–L1026 (2006).
   PubMed Web of Science ®Google Scholar
• Ritter T, Kupiec-Weglinski JW. Gene therapy for the prevention of ischemia/reperfusion injury in organ transplantation. Curr. Gene Ther.5(1), 101–109 (2005).
   PubMed Web of Science ®Google Scholar
• Cassivi SD, Cardella JA, Fischer S, Liu M, Slutsky AS, Keshavjee S. Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J. Heart Lung Transplant.18(12), 1181–1188 (1999).
   PubMedGoogle Scholar
• Chapelier A, Danel C, Mazmanian M et al. Gene therapy in lung transplantation: feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum. Gene Ther.7(15), 1837–1845 (1996).
   PubMedGoogle Scholar
• Pellegrini C, O’Brien T, Jeppsson A et al. Influence of temperature on adenovirus-mediated gene transfer. Eur. J. Cardiothorac. Surg.13(5), 599–603 (1998).
   PubMedGoogle Scholar
• Yeung JC, Wagnetz D, Koike T, Rubacha M, Cypel M, Keshavjee S. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation. J. Heart Lung Transplant.29(2 Suppl.), S95 (2010).
   Google Scholar
• Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl Acad. Sci. USA106(38), 16357–16362 (2009).
   PubMed Web of Science ®Google Scholar
• Ott HC, Clippinger B, Conrad C et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med.16(8), 927–933 (2010).
   PubMed Web of Science ®Google Scholar
• Petersen TH, Calle EA, Zhao L et al. Tissue-engineered lungs for in vivo implantation. Science329(5991), 538–541 (2010).
   PubMed Web of Science ®Google Scholar
• Grootenboers MJ, Heeren J, van Putte BP et al. Isolated lung perfusion for pulmonary metastases, a review and work in progress. Perfusion21(5), 267–276 (2006).
   PubMedGoogle Scholar
• Van Schil PE, Hendriks JM, van Putte BP et al. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases. Eur. J. Cardiothorac. Surg.33(3), 487–496 (2008).
   PubMedGoogle Scholar
• Den Hengst WA, Van Putte BP, Hendriks JM et al. Long-term survival of a Phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases. Eur. J. Cardiothorac. Surg.38(5), 621–627 (2010).
   PubMed Web of Science ®Google Scholar